The global race to harness the power of artificial intelligence (AI) has begun. President Donald Trump got it right from the ...

The visit—Huang’s third to China this year—coincided with a series of significant developments: regulatory approval for ...

Drug discovery has long been criticized for its slow, costly, and failure-prone nature. Traditional approaches, particularly ...

Human Capital development is undergoing a radical transformation as Artificial Intelligence (AI) continues to evolve and ...

As artificial intelligence (AI) reshapes industries, its transformative potential comes with a complex web of regulatory ...

Nvidia stock hits record highs as U.S. export licenses unlock access to China’s $50B AI market. Click here to read an ...

With the rise of advanced simulation and model-informed drug development (MIDD) techniques like digital twins, researchers ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

The focus on artificial intelligence, part of a partnership with Google, raises concerns among some environmentalists and ...

AI analysis flags LINK, ADA, and AVAX as undervalued, projecting 44%–264% upside within 30 days on rising interest.

In our new artificial intelligence era, power isn't just about computing abilities—it's about who controls the energy grid.

NETSOL Technologies, Inc. (Nasdaq: NTWK), a leader in AI-powered solutions and services enabling OEMs, dealerships and ...